Unlike other existing inhibitors (ARV-771, IPZ, U0126, and LY294002), the aminocyclopropenone ACP-1n, as a novel inhibitor of LLPS formation, induced decreases in nucleus size and CRC cell proliferation via epigenetic pathways associated with BRD4 occupancy (Figure 6). This evidence concerns the gene BRD4 and colorectal carcinoma.